News

Next month, a one-hour webinar will bring together leading experts from Europe and the United States to discuss ex-vivo lung perfusion (EVLP).

In response to the Organ Procurement and Transplantation Network (OPTN) special call for public comment, the ISHLT has submitted official comments on a proposal entitled "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates.”

The ISHLT Governance Nominating Committee invites ISHLT members to submit self-nominations to serve on the ISHLT Board of Directors. Review the Call for Nominations and consider submitting a nomination packet for one of four open Director positions.

During the 45th Annual Meeting & Scientific Sessions in Boston, ISHLT announced $250,000 USD in grants funded by the ISHLT Foundation to support research to advance heart and lung disease.

The ISHLT International Thoracic Organ Transplant (TTX) Registry hosted a special session at ISHLT2025 in Boston to highlight the recent progress in international data sharing with the ISHLT Registry following the challenges of evolving privacy regulations.

On 30 April, at the closing General Session at the ISHLT 45th Annual Meeting & Scientific Sessions in Boston, the ISHLT Foundation announced Daniel Goldstein, MD from Montefiore Medical Center in Bronx, NY USA as the 2025 recipient of the Francis D. Pagani, MD Endowed Mentorship Award.

ISHLT2025 featured multidisciplinary science and global collaboration. This was the largest ISHLT Annual Meeting ever, where over 4,500 attendees gathered in Boston, MA USA. Catch up on all the meeting highlights.

ISHLT leadership is proud to endorse two joint sessions with the Heart Association of the Spanish Society of Cardiology which will be held during the annual congress of the Spanish Heart Failure Association in Zaragoza, Spain on 12 June, 2025.

From among the more than 2,000 presentations in at the Annual Meeting in Boston, three abstracts were selected to receive awards to recognize excellence from early career investigators.

As announced at the ISHLT2025 meeting in Boston last month, Melissa Cousino, PhD, will serve as the Scientific Program Chair for the ISHLT’s 47th Annual Meeting & Scientific Sessions. Dr. Cousino will be the first non-physician ISHLT member to hold this position.

Barostim is a novel device therapy that works with GDMT to targets the neurohormonal pathways responsible for heart failure progression and symptoms. Watch this symposium recording from CVRx to learn more.

ISHLT webinar recordings are open to the entire community any time you need a little extra insight. Watch past recordings and keep an eye on future programs.

First author Peter Cho and senior author Abbas Ardehali, MD, discuss the paper, “Severe primary graft dysfunction in heart transplant recipients using donor hearts after circulatory death: a United States Experience.”

ISHLT en Español llevará a cabo un webinar sobre manejo de infecciones en trasplantes de pulmón y corazón el 4 de junio próximo. El evento es totalmente gratuito y todos son bienvenidos a participar.

All ISHLT members are invited to join Society leaders and fellow members for the ISHLT 2025 Annual Business Meeting—a chance to hear key updates and discuss issues of interest to the ISHLT community on Wednesday 21, May.

Final Day of ISHLT2025

During the final General Session of the ISHLT’s 45th Annual Meeting & Scientific Sessions, ISHLT recognized outstanding achievements in research and groundbreaking scientific contributions.

Tuesday at ISHLT2025

At the ISHLT Annual Meeting in Boston, Dr. Jeffrey Teuteberg showed how molecular testing like cell-free DNA is reducing biopsies, personalizing post-transplant care, and improving outcomes through earlier rejection detection and easier remote monitoring.

Ready for Day Two of ISHLT2025?